According to Fortune “the stock market was up on Thursday, but you wouldn’t know it if you were a health care investor. Pharmaceutical and biotech stocks were pummeled, diverging from the broader market for the first time in recent days.The weird part: There was no relevant news or obvious reason for the slump”. No obvious reasons????? Continue reading »
KEY IDEA: Biopharma has to understand it has responsibilities to a wider community than its own shareholders. Using PR talking points only serve to make pharma executives feel good about themselves while the public and politicians zero in on high drug prices and a lack of transparency. Continue reading »
KEY TAKEAWAY: The drug companies could care less about consumers and patients. Want proof? Look no further than the dismissal of patient concerns at a meeting in San Francisco when one executive said “Gregg Alton, the executive vice president for corporate and medical affairs, joked that he goes running. Then his tone turned serious as he talked about research, innovation, and the value of life-saving new drugs. “I sleep quite well,” he concluded. Continue reading »
KEY TAKEAWAY: The biggest threat to healthcare is not drug pricing, it’s ourselves. Research from the American Diabetes Association shows the total cost of diabetes was $245 billion in 2012 — a 41% increase from the $174 billion spent in 2007.
Continue reading »
KEY TAKEAWAY: The American Medical Association today called for a ban on direct-to-consumer advertising of prescription drugs, with physicians suggesting that TV and magazine ads could be contributing to the rising cost of expensive treatments however, they are wrong and need to look at the facts.
Continue reading »
KEY IDEA: Shareholders vs. patients, who is more important? One pharma CEO is leaving no doubt that shareholders come first and has raised prices to appease the Street. Can CEO’s really balance patient needs with shareholder expectations? Continue reading »
KEY TAKEAWAY: The biggest threat to healthcare is NOT high drug prices but, rather obesity. Unless further government action is taken, the global obesity rate will rise another 4% by 2025, according to a new report from the World Obesity Federation. Continue reading »
KEY THOUGHT: Even if all prescription drugs were free health care costs would continue to climb because of unhealthy lifestyles. About half of American adults have either diabetes or prediabetes, a new study says and the cost of that alone could send healthcare costs into orbit. However, the media is too focused on the cost of prescription drugs. Continue reading »
KEY TAKEAWAY: Via the Finacial Times “Pharmaceutical companies must move towards new pricing models based on outcomes for patients if cash-strapped health systems are to remain solvent, according to the chief executive of Novartis.” Continue reading »
KEY TAKEAWAY: Drug prices, and big pharma, are going to be squarely in the crosshairs of big pharma in the next general election. He echoes the sentiments of a lot of the American Public and you can bet that insurers, as well as politicians, are going to do something about it to win votes. Continue reading »
KEY TAKEAWAY: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with 6,484 products in active development across all indications, but 90% of these drugs will not make it into Phase III clinical trials. Continue reading »